Showing results (41-50 of 55) with videos related to
Sort By:
Pageof 6
Neuropathology and Applied Neurobiology|July 14, 2022
The genomic landscape of dysembryoplastic neuroepithelial tumours and a comprehensive analysis of recurrent casesMélanie Pagès, Marie-Anne Debily, Frédéric Fina, et al.Neuro-Oncology|February 7, 2020
Imaging growth as a predictor of grade of malignancy and aggressiveness of IDH-mutant and 1p/19q-codeleted oligodendrogliomas in adultsAlexandre Roux, Arnault Tauziede-Espariat, Marc Zanello, et al.Neurology|December 28, 2020
Meningioangiomatosis: Multimodal Analysis and Insights From a Systematic ReviewAlexandre Roux, Marc Zanello, Rossella Letizia Mancusi, et al.Histopathology|November 22, 2022
NTRK-rearranged spindle cell neoplasms are ubiquitous tumours of myofibroblastic lineage with a distinct methylation classArnault Tauziède-Espariat, Mathilde Duchesne, Jessica Baud, et al.Cancer Biomarkers : Section a of Disease Markers|August 12, 2017
Clinical validation of the CE-IVD marked Therascreen MGMT kit in a cohort of glioblastoma patientsVéronique Quillien, Audrey Lavenu, François Ducray, et al.Oncotarget|August 20, 2016
Validation of the high-performance of pyrosequencing for clinical MGMT testing on a cohort of glioblastoma patients from a prospective dedicated multicentric trialVéronique Quillien, Audrey Lavenu, François Ducray, et al.Acta Neuropathologica|August 31, 2016
Prognostic impact of the 2016 WHO classification of diffuse gliomas in the French POLA cohortEmeline Tabouret, Anh Tuan Nguyen, Caroline Dehais, et al.Neuro-Oncology|March 18, 2016
Supratentorial clear cell ependymomas with branching capillaries demonstrate characteristic clinicopathological features and pathological activation of nuclear factor-kappaB signalingDominique Figarella-Branger, Emmanuèle Lechapt-Zalcman, Emeline Tabouret, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 20, 2019
Outcome of Patients with Non-Small Cell Lung Cancer and Brain Metastases Treated with Checkpoint InhibitorsLizza E L Hendriks, Clemence Henon, Edouard Auclin, et al.Nature Communications|June 20, 2018
A recurrent point mutation in PRKCA is a hallmark of chordoid gliomasShai Rosenberg, Iva Simeonova, Franck Bielle, et al.Pageof 6